| 1.49 |  -0.02 / -1.32% |
Data as of 3:59pm ET | Day’s Change |
| 1.51 |  +0.02 / +1.34% |
Volume: 100.00 |
| Previous close | 1.51 |
| Today’s open | 1.54 |
| Day’s range | 1.49 - 1.61 |
| Volume | 284,134 |
| Average volume (3 months) | 255,130 |
| Market cap | $67.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -308.33% |
| Earnings growth (this year) | +20.02% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -59.38% |
| P/E ratio | NM |
| Price/Sales | 13.93 |
| Price/Book | 10.66 |
| Today’s change | Today’s % change | |
|---|---|---|
| BIODBiodel Inc | -0.41 | -8.61% |
| TKMRTekmira Pharmaceutic... | -0.02 | -0.42% |
| --Ophthalix Inc | 0.00 | 0.00% |
| RDHLRedhill Biopharma Lt... | -0.15 | -1.40% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $3.6M |
| Annual profit (last year) | -$18.2M |
| Net profit margin | -510.66% |
Sector Health Technology |
Industry Biotechnology |
President & Director Michael Fonstein, PhD |
Chief Executive Officer, COO & Director Yakov Kogan, PhD, MBA |
Corporate headquarters Buffalo, New York |
.
